Ключевые слова
Аннотация
Mazkur tezisda virusli gepatit B va C bilan kasallangan bemorlarda ko‘p dorilarga chidamli o‘pka silining klinik kechish xususiyatlari tahlil qilingan. Tadqiqot natijalariga ko‘ra, gepatit virusi fonida tuberkulyoz infeksiyasining kechishi murakkablashadi, davolash jarayonida gepatotoksiklik xavfi ortadi, immun javob zaiflashadi hamda infeksiyaning surunkali shaklga o‘tish ehtimoli kuchayadi. Bunday bemorlarda silning infiltrativ-destruktiv va kavernoz shakllari ustuvor bo‘lib, jigar faoliyatidagi buzilishlar davolash rejimini individual tarzda tanlashni talab qiladi. Shuningdek, maqolada gepatoprotektorlar va antiviral vositalar bilan kompleks davolash usullarining afzalliklari yoritilgan.
Библиографические ссылки
WHO. (2023). Global Tuberculosis Report. Geneva: World Health Organization.
Dara, M., et al. (2019). Management of tuberculosis in patients with chronic hepatitis B and C infection. European Respiratory Journal, 54(5), 1900876.
Jacobson, K. R., et al. (2018). Impact of hepatitis co-infection on tuberculosis treatment outcomes: A cohort study. Clinical Infectious Diseases, 67(5), 738–744.
Mavlonov, A. S., & Yusupov, B. R. (2021). Virusli gepatitli bemorlarda sil kasalligi kechishi va davolash taktikasi. Tibbiyot va hayot, №3, 17–21.
Ziyodova, M. R. (2022). Gepatotoksiklik xatarlarini baholashda laborator monitoringning o‘rni. O‘zbekiston vrachlar jurnali, №4, 31–34.
Ministry of Health of Uzbekistan. (2020). National guidelines for the treatment of drug-resistant tuberculosis.